-+ 0.00%
-+ 0.00%
-+ 0.00%
Top 3 Health Care Stocks You'll Regret Missing This Quarter
Share
Listen to the news

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Legend Biotech Corp (NASDAQ:LEGN)

  • On July 27, Legend Biotech announced the resignation of its CEO Ying Huang. The company’s stock fell around 32% over the past month and has a 52-week low of $16.25.
  • RSI Value: 29.5
  • LEGN Price Action: Shares of Legend Biotech rose 2.5% to close at $19.01 on Monday.
  • Edge Stock Ratings: 7.55 Momentum score.

PTC Therapeutics, Inc. (NASDAQ:PTCT)          

  • On July 30, PTC Therapeutics posted upbeat quarterly results. “Our teams delivered another strong quarter enabling us to again raise 2026 product revenue guidance,” said Matthew B. Klein, M.D., Chief Executive Officer. The company’s stock fell around 20% over the past month and has a 52-week low of $43.18.
  • RSI Value: 28.6   
  • PTCT Price Action: Shares of PTC Therapeutics rose 0.2% to close at $68.12 on Monday.
  • Benzinga Pro’s charting tool helped identify the trend in PTCT stock.

Indivior Pharmaceuticals Inc (NASDAQ:INDV)

  • Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals on Monday agreed to unite through a tax-free all-stock merger of equals, forming a central nervous system (CNS) biopharmaceutical company. The combined business will operate as Supernus and trade on the Nasdaq Global Market under the ticker symbol "SUPN." The company’s stock fell around 7% over the past five days and has a 52-week low of $42.81.
  • RSI Value: 27.7
  • INDV Price Action: Shares of Indivior Pharmaceuticals fell 6.6% to close at $37.37 on Monday.
  • Benzinga Pro’s signals feature notified of a potential breakout in INDV shares.

Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending